| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |